Menotropins

Generic Name: Menotropins

Brand Names: Menopur

Drug Type: Biotech

Chemical Formula: -

CAS Number: 9002-68-0

Unique Ingredient Identifier: 8FYM5179QJ

Background: Menotropins contains follicle stimulating hormone (FSH) and luteinizing hormone (LH) purified from the urine of postmenopausal women. It is used as a fertility medication that is injected either subcutaneously or intramuscularly. It is composed of LH with 2 subunits, alpha = 92 residues, beta = 121 residues and FSH with 2 subunits, alpha = 92 residues, beta=111 residues.

Indication: For the treatment of female infertility

Associated Conditions: -

Associated Therapies: Assisted Reproductive Technology therapy

Clinical Trials

Gonadotropin Type in Ovarian Stimulation

Phase 4

Completed

Conditions: Infertility

Interventions: Drug: recombinant FSH
Drug: Urinary FSH
Drug: hMG

First Posted Date: 2015-05-07

Last Posted Date: 2015-05-07

Lead Sponsor: IVI Madrid

Target Recruit Count: 100

Registration Number: NCT02437032

Mono-menotropins Versus rFSH Protocol on Embryo Quality

Not Applicable

Completed

Conditions: Infertility
Fertility

Interventions: Drug: Recominant Follicle Stimulating Hormone (rFSH)
Drug: menotropin

First Posted Date: 2015-04-16

Last Posted Date: 2020-08-12

Lead Sponsor: Main Line Fertility Center

Target Recruit Count: 109

Registration Number: NCT02418533

Locations: 🇺🇸
Main Line Fertility Center, Bryn Mawr, Pennsylvania, United States

Randomized Controlled Trial Comparing Embryonic Quality in rFSH Versus hMG in IVF Protocol With GnRH Antagonist

Phase 4

Completed

Conditions: Infertility

Interventions: Drug: rFSH
Drug: HMG

First Posted Date: 2015-04-09

Last Posted Date: 2015-08-21

Lead Sponsor: Hospital de Clinicas de Porto Alegre

Target Recruit Count: 188

Registration Number: NCT02412904

Locations: 🇧🇷
Centro de Reproduçao Humana Insemine, Porto Alegre, RGS, Brazil

Ovarian Stimulation With Recombinant Gonadotropins vs. Human Menopausal Gonadotropin in In Vitro Fertilization

Completed

Conditions: Infertility

Interventions: Drug: rFSH plus rLH
Drug: hMG

First Posted Date: 2014-12-23

Last Posted Date: 2014-12-23

Lead Sponsor: University of Turin, Italy

Target Recruit Count: 848

Registration Number: NCT02322398

Locations: 🇮🇹
Physiopathology of Reproduction and IVF Unit, S. Anna Hospital, Torino, Italy

Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation

Phase 4

Completed

Conditions: Egg Donation

Interventions: Drug: Follistim
Drug: Ganirelix
Drug: Menotropins
Drug: Leuprolide
Procedure: Transvaginal ultrasound guided needle aspiration of oocytes

First Posted Date: 2014-02-24

Last Posted Date: 2018-03-23

Lead Sponsor: Michigan Reproductive Medicine

Target Recruit Count: 38

Registration Number: NCT02069808

Locations: 🇺🇸
Michigan Reproductive Medicine, Bloomfield Hills, Michigan, United States

An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos

Completed

Conditions: Infertility

Interventions: Drug: menotropin

First Posted Date: 2013-12-23

Last Posted Date: 2017-08-28

Lead Sponsor: Ferring Pharmaceuticals

Target Recruit Count: 738

Registration Number: NCT02018159

Locations: 🇩🇰
Fertilitetsklinikken Hospitalsenheden Horsens, Regionshospitalet Horsens (there may be other sites in this country), Horsens, Denmark

Hormonal Stimulation in IUI Treatment: Is Clomifen Combined With Ethinyl Estradiol Better, Worse or Equal to Menopur

Not Applicable

Completed

Conditions: Subfertility

Interventions: Drug: Menotropins
Drug: Clomifen, Ethinyl Estradiol

First Posted Date: 2012-04-03

Last Posted Date: 2014-09-10

Lead Sponsor: University Hospital, Gasthuisberg

Target Recruit Count: 371

Registration Number: NCT01569945

Locations: 🇧🇪
Leuven University Fertility Center, Leuven, Vlaams Brabant, Belgium

hMG or Recombinant FSH on OHSS Prevention in PCOS Patients Undergoing IVF

Phase 4

Completed

Conditions: Polycystic Ovary Syndrome

Interventions: Drug: rFSH
Drug: HMG

First Posted Date: 2011-06-03

Last Posted Date: 2012-03-29

Lead Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital

Target Recruit Count: 80

Registration Number: NCT01365936

Locations: 🇹🇷
Zekai Tahir Burak women's research and Training Hospital, Ankara, Turkey

Assessment of the Effectiveness of Menopur in Intrauterine Insemination

Completed

Conditions: Infertility

Interventions: Drug: hMG

First Posted Date: 2011-05-17

Last Posted Date: 2011-05-17

Lead Sponsor: Ferring Pharmaceuticals

Target Recruit Count: 207

Registration Number: NCT01354834

Locations: 🇪🇸
Investigational site, Valladolid, Spain

Safety and Efficacy Study in in Vitro Fertilisation (IVF) Patients

Phase 3

Completed

Conditions: Infertility

Interventions: Drug: Menotropins

First Posted Date: 2011-03-11

Last Posted Date: 2016-07-22

Lead Sponsor: IBSA Institut Biochimique SA

Target Recruit Count: 270

Registration Number: NCT01312766

Locations: 🇩🇰
Fertility clinic at Hvidovre Hospital, Hvidovre, Copenhagen, Denmark
🇬🇧
Midland Fertility Services, Aldridge, West Midlands, United Kingdom
🇩🇰
Odense Universitetshospital, Odense, Odensee C, Denmark

and more 3 locations

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy